NISIBRO
(Bromhexine hcl 2 mg + Guaifenesin 50 mg + Terbutaline sulphate 1.25 mg )
Overview:
NISIBRO SYRUP contains-
Bromhexine hcl decreases the viscosity of mucus in the airway, enhancing mucus clearance.
Guaifenesin enhances mucous membrane activity in the upper and lower airways by removing accumulated secretions
Terbutaline is used as a bronchodilator
Bromhexine is mucolytic agent.
Guaifenesin is an expectorant. Terbutaline is a beta-2 adrenergic agonist
Guaifenesin is an expectorant. Terbutaline is a beta-2 adrenergic agonist
Bronchiectasis
Common Cold
Cough
Nasal Congestion
Bronchospasm
COPD
Emphysema
ADULTS- 2 Teaspoonful (10ml) thrice daily.
CHILDREN -6-12yrs-1 Teaspoonful (5ml) thrice daily. 2-6yrs 1/2 teaspoon (2.5ml) thrice daily.
CHILDREN -6-12yrs-1 Teaspoonful (5ml) thrice daily. 2-6yrs 1/2 teaspoon (2.5ml) thrice daily.
Bromhexine inhibits and activates the TMPRSS2 receptor in humans which plays an important role in influenza A and Middle East Respiratory Syndrome (MERS)
Guaifenesin aids in thinning bronchial secretions and liquifying phlegm (mucus) to help clear the bronchial passageways of irritating mucus.
Terbutaline increases CAMP, activates protein kinase A, inactivates myosin light-chain kinase, activates myosin light-chain phosphatase, and relaxes smooth muscles